These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 26964395

  • 1. [Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
    Ogawa Y, Yuta A, Arikata M, Kozaki H, Ohta N, Suzuki Y, Shimizu T.
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Dec; 118(12):1429-35. PubMed ID: 26964395
    [Abstract] [Full Text] [Related]

  • 2. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
    [Abstract] [Full Text] [Related]

  • 3. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H.
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [Abstract] [Full Text] [Related]

  • 4. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
    Oka A, Yuta A, Okawa Y, Masuno S, Tsunoda T, Takahara E, Terada A, Kanai K, Nagakura H, Mimura H, Arao H, Ueyama S, Ueyama A, Tokuda R, Bamba H, Nakazato H, Nakazato M, Amesara R, Nakai S, Araki S, Sakaida M, Tokuriki M, Hama T, Chiba M, Ikeda H, Togawa A, Tsuzuki H, Hyo Y, Niitsu S, Ohkawa C, Nakamoto S, Takeo T, Kumanomidou H, Kanai K, Kitamura H, Sugiura R, Okano M.
    Arerugi; 2023 Aug; 72(9):1138-1146. PubMed ID: 37967960
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 Aug; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 6. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y, Yokomoto Y, Ohashi-Doi K.
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [Abstract] [Full Text] [Related]

  • 7. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 8. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K.
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [Abstract] [Full Text] [Related]

  • 9. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K, Otsuka H, Matsune S, Okubo K.
    Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
    [Abstract] [Full Text] [Related]

  • 10. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T, Kitamura Y, Kamimura S, Naito K, Takeda N.
    Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
    [Abstract] [Full Text] [Related]

  • 11. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Arerugi; 2015 Dec; 64(10):1323-33. PubMed ID: 26727137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
    Nomura T, Suzuki M, Yokota M, Nakamura Y, Ozeki K, Ito Y, Tsuge I, Saitoh S.
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
    Yuta A, Ogawa Y, Kozaki H, Shimizu T.
    Arerugi; 2023 Jul; 72(10):1230-1239. PubMed ID: 38092399
    [Abstract] [Full Text] [Related]

  • 19. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T.
    Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.
    Yang Y, Zhou W, Chen A.
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):348-353. PubMed ID: 27566862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.